Rx|X specializes in comprehensive compliance reviews, independent audits, policy analysis and reports, and litigation support for stakeholders in the 340B Drug Discount Program.
Our 16 years of direct experience with these pharmaceutical programs place Rx|X in a unique position to offer perspective, a proper assessment of potential issues, and sound advice. We offer state-of-the art research, analytics, and consulting services, based on our senior level experience with the federal government’s principal oversight agency for HHS and through our ongoing engagements with federal and state governments, 340B covered entities, law firms and advocacy organizations. Our broad and varied experience gives us a distinct advantage in understanding all relevant issues and offering tailored and pragmatic solutions for our clients.
(click on the box for more information)